Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Erik Ekker Solberg,
Sickle cell trait associated with a RR of death of 37 times in national collegiate athletic association football athletes: a database with 2 million athlete-years as the denominator Harmon KG et al. Br J Sports Med 2012;46:325-330 doi:10.1136/bjsports-2011-090896
The cost-effectiveness of sport screening has been criticised. A way of improving efficacy of screening is a priori to identify high-risk individuals. In a register of two million American college athletes, exertional sudden death in athletes with sickle cell trait (SCT) and cost-effectiveness of different screening models were explored. By reviewing all causes of sudden death in the period 2004-2008, the authors identified 273 deaths in a total of 1.9 million athlete-participant-years. In football, 20 deaths were due to medical causes; nine were cardiac, five were in athletes with SCT. Thirteen of the 20 deaths due to medical causes occurred during exertion; cardiac (6) and SCT-associated (5). All deaths associated with SCT occurred in black Division I football athletes. The risk of exertional death in Division I football players with SCT was 1:827 which was 37 times higher than in athletes without SCT. Screening only incoming athletes was cost-effective in all groups ($ 30/test), costing $2435 per year life saved (black football athletes) to $47 816 (all athletes). Even when taken into account the small number of SCT-related deaths, exertional death in athletes with SCT occurs at a higher rate than previously expected.
This article expands the field of sudden death in sports and reminds us of other etiologies beyond the cardiac structure.